Solitary giant neurofibroma of the neck subjected to photodynamic therapy: case study.

Head and Neck Optical Diagnostics Society Pub Date : 2012-01-01 Epub Date: 2012-06-06 DOI:10.1186/1758-3284-4-30
Zaid Hamdoon, Waseem Jerjes, Raed Al-Delayme, Colin Hopper
{"title":"Solitary giant neurofibroma of the neck subjected to photodynamic therapy: case study.","authors":"Zaid Hamdoon,&nbsp;Waseem Jerjes,&nbsp;Raed Al-Delayme,&nbsp;Colin Hopper","doi":"10.1186/1758-3284-4-30","DOIUrl":null,"url":null,"abstract":"<p><p>Photodynamic therapy (PDT) - the fourth modality - has been successfully used in the management of early and advanced pathologies of the head and neck. We studied the effect of this modality on a giant solitary neurofibroma of the neck. A 70-year-old Caucasian female presented with left neck pain and disfigurement associated with slight shortness of breath and dysphagia. Examination revealed a large mass in the neck with no neurovascular compromise. Magnetic resonance imaging (MRI) reported a heterogeneously enhancing mass extending from the left angle of the mandible to the base of the neck. A core biopsy was performed and histopathological examination revealed a disorganised array of peripheral nerve fascicles. The patient elected to receive photodynamic therapy as the primary intervention. The multi-disciplinary meeting approved the treatment plan. The photosensitizing agent was mTHPC (0.15 mg/kg), which was systemically administered 96-hours prior to ultrasound (US)-guided light delivery to the mass, which was undertaken under general anaesthesia. Recovery was uneventful. Post-PDT follow-up showed that the patient's pain, dysphagia and shortness of breath issues had improved. The disfigurement of the neck caused by the mass was no longer a problem. Three months post-PDT, MRI revealed a significant reduction in the neurofibroma size. PDT was proven as a successful primary intervention for this pathology. However, higher evidence-based studies are required before this therapy can be proposed as a replacement to any of the other conventional therapies.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-4-30","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Head and Neck Optical Diagnostics Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1758-3284-4-30","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/6/6 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17

Abstract

Photodynamic therapy (PDT) - the fourth modality - has been successfully used in the management of early and advanced pathologies of the head and neck. We studied the effect of this modality on a giant solitary neurofibroma of the neck. A 70-year-old Caucasian female presented with left neck pain and disfigurement associated with slight shortness of breath and dysphagia. Examination revealed a large mass in the neck with no neurovascular compromise. Magnetic resonance imaging (MRI) reported a heterogeneously enhancing mass extending from the left angle of the mandible to the base of the neck. A core biopsy was performed and histopathological examination revealed a disorganised array of peripheral nerve fascicles. The patient elected to receive photodynamic therapy as the primary intervention. The multi-disciplinary meeting approved the treatment plan. The photosensitizing agent was mTHPC (0.15 mg/kg), which was systemically administered 96-hours prior to ultrasound (US)-guided light delivery to the mass, which was undertaken under general anaesthesia. Recovery was uneventful. Post-PDT follow-up showed that the patient's pain, dysphagia and shortness of breath issues had improved. The disfigurement of the neck caused by the mass was no longer a problem. Three months post-PDT, MRI revealed a significant reduction in the neurofibroma size. PDT was proven as a successful primary intervention for this pathology. However, higher evidence-based studies are required before this therapy can be proposed as a replacement to any of the other conventional therapies.

Abstract Image

Abstract Image

单发巨大的颈部神经纤维瘤接受光动力治疗:个案研究。
光动力疗法(PDT) -第四种模式-已成功地用于头颈部早期和晚期病理的管理。我们研究了这种方式对颈部巨大孤立神经纤维瘤的影响。一位70岁的白人女性表现为左颈部疼痛和毁容,伴有轻微呼吸短促和吞咽困难。检查发现颈部有一个大肿块,未见神经血管受损。磁共振成像(MRI)报告了一个非均匀增强的肿块,从下颌骨的左角延伸到颈部的底部。进行了核心活检,组织病理学检查显示周围神经束排列紊乱。患者选择接受光动力治疗作为主要干预。多学科会议批准了治疗方案。光敏剂为mTHPC (0.15 mg/kg),在全身麻醉下,于超声(US)引导光照射肿块前96小时全身给药。恢复过程平淡无奇。pdt后随访显示,患者的疼痛、吞咽困难和呼吸短促问题有所改善。由肿块引起的颈部畸形不再是一个问题。pdt后3个月,MRI显示神经纤维瘤大小明显减小。PDT被证明是一种成功的初级干预这种病理。然而,在提出这种疗法替代任何其他传统疗法之前,需要更高的循证研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信